The effect of zoledronic acid on aromatase inhibitor associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole: 36 months follow-up of ZO-FAST.
Keyword(s):
Keyword(s):
2008 ◽
Vol 6
(7)
◽
pp. 197
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2007 ◽
Vol 5
(4)
◽
pp. 186-187
◽
Keyword(s):
Keyword(s):
2011 ◽
Vol 29
(15_suppl)
◽
pp. e11111-e11111
◽
Keyword(s):
Keyword(s):
Keyword(s):